← Leaderboards
Elizabeth B Lamont
University Of Chicago
$3,688,446
Attributed
$3,688,446
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $722K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,688,446 · 6
By mechanism
R01$2,039,572 · 1
R21$996,067 · 3
K07$652,806 · 1
P01$1 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Charles M Rudin$26,521,794
- Daniel E Johnson$10,482,584
- Karen E Kim$11,883,483
- Olufunmilayo I Olopade$31,360,913
- Kathleen Joyce Millen$25,929,838
Others in their field
Top investigators on “Medicare”
- David R. Weir · University Of Michigan At Ann Arbor$380,546,860
- Robert J Willis · University Of Michigan At Ann Arbor$79,645,109
- Judith Kasper · Johns Hopkins University$77,526,591
- Vicki A. Freedman · Madlyn/Leonard Abramson Ctr/Jewish Life$59,405,180
- Daniel Ernest Ford · Johns Hopkins University$56,884,093
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
MedicareBaseOlder PatientPhysiciansSiteMalignant NeoplasmsElderlyOncologyCancer PatientStagingCohortCancer CareCaringAreaData SetReportingDiagnosisOncologistEnrollmentChemotherapyGeneral PopulationClinical TrialsChemotherapy-Oncologic ProcedureEffectiveness
Grant awards (17)
Comparative Effectiveness of Treatment Regimens in Lung Cancer$211,875
R21 · FY2014 · AG · contact PI
Population-Based Assessment of Cancer Trial Generalizability in the Elderly$362,337
R01 · FY2012 · CA · contact PI
Do Medicare Claims Measure Cancer Relapse Patients: An External Validation Study$221,198
R21 · FY2012 · CA · contact PI
Population-Based Assessment of Cancer Trial Generalizability in the Elderly$390,756
R01 · FY2011 · CA · contact PI
Do Medicare Claims Measure Cancer Relapse Patients: An External Validation Study$184,331
R21 · FY2011 · CA · contact PI
Population-Based Assessment of Cancer Trial Generalizability in the Elderly$312,343
R01 · FY2010 · CA · contact PI
Population-Based Assessment of Cancer Trial Generalizability in the Elderly$422,334
R01 · FY2009 · CA · contact PI
Population-Based Assessment of Cancer Trial Generalizability in the Elderly$551,802
R01 · FY2008 · CA · contact PI
Development of Hierarchical Neighborhood Data Regarding Cancer in the Elderly$170,178
R21 · FY2008 · AG · contact PI
Neighborhood Effects on Cancer Course in the Aged$1
P01 · FY2008 · AG · contact PI
Development of Hierarchical Neighborhood Data Regarding Cancer in the Elderly$208,485
R21 · FY2007 · AG · contact PI
Do Medicare Claims Measure Chemotherapy Use and Outcomes$130,363
K07 · FY2006 · CA · contact PI
Do Medicare Claims Measure Chemotherapy Use and Outcomes$130,595
K07 · FY2005 · CA
Do Medicare Claims Measure Chemotherapy Use and Outcomes$130,595
K07 · FY2004 · CA
Do Medicare Claims Measure Chemotherapy Use and Outcomes$52,211
K07 · FY2004 · CA
Do Medicare Claims Measure Chemotherapy Use and Outcomes$77,984
K07 · FY2003 · CA
Do Medicare Claims Measure Chemotherapy Use and Outcomes$131,058
K07 · FY2002 · CA